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Abstract: Rabies, a zoonotic encephalitis due to transmission of a lyssavirus, such as rabies virus
(RABV), has the highest case fatality of any infectious disease. A global program for the elimination of
human rabies caused by dogs is proposed for realization by 2030. Sensitive, specific, and inexpensive
diagnostic tests are necessary for enhanced surveillance to detect infection, inform public health and
veterinary professionals during risk assessments of exposure, and support overall programmatic
goals. Multiple laboratory techniques are used to confirm a suspect case of rabies. One method for the
detection of lyssavirus antigens within the brain is the direct rapid immunohistochemical test (dRIT),
using light microscopy, and suitable for use under field conditions. Besides dogs, other major RABV
reservoirs reside among mammalian mesocarnivores and bats. To date, use of the dRIT has been
applied primarily for the diagnosis of RABV in suspect mesocarnivores. The purpose of this study was
to assess the usefulness of the dRIT to the diagnosis of rabies in bats, compared to the gold-standard,
the direct fluorescent antibody test (DFAT). Brains of 264 suspect bats, consisting of 21 species from
Arizona and Texas, were used in the evaluation of the dRIT. The overall sensitivity of the dRIT was
100% (0.969–1.0, 95% CI) and the specificity was 94.6% (0.896–0.976, 95% CI), comparable to the DFAT.
This preliminary study demonstrated the utility of the dRIT in the confirmation of RABV infection
in bats. Future studies should include additional geographic, lyssavirus, and mammalian species
representations for broader application during enhanced rabies surveillance, with incorporation of
any potential adjustments to standard protocols, as needed.
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1. Introduction

published maps and institutional affil-

Rabies is an acute, progressive encephalitis caused by infection with highly neurotropic
RNA viruses in the genus Lyssavirus, Family Rhabdoviridae [1]. This zoonosis is global in
distribution and causes millions of exposures and tens of thousands of human fatalities
annually [2]. More than 16 different lyssaviruses were described over the past 60 years,
with several others under taxonomic consideration as additional species [3]. Globally,
most deaths are due to bites from dogs infected with rabies virus (RABV). However, all
mammals are believed susceptible to RABV infection [4]. Significant reservoirs of RABV
include mesocarnivores, such as canines (e.g., Canis spp; Lupulella spp.), ferret-badgers (e.g.,
Melogale spp.), foxes (e.g., Urocyon cinereoargenteus; Vulpes spp.), mongooses (e.g., Cynictis
penicillate; Urva auropunctata), procyonids (e.g., Procyon lotor), and skunks (e.g., Mephitis
mephitis), as well as multiple bat spp. Within the Americas, RABV is the only lyssavirus
characterized to date.
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Typically, as quintessential neurotropic pathogens, a diagnosis of rabies in animals
consists of the postmortem demonstration of specific viral antigens or nucleic acids within
the central nervous system [5,6]. The direct fluorescent antibody test (DFAT) is a goldstandard method, used for the detection of lyssavirus antigens in the brains of suspect
cases [5–7]. Besides the DFAT, the direct rapid immunohistochemistry test (dRIT) is also a
recommended confirmatory method, using light microscopy and biotinylated antibodies
for the observation of intra-neuronal inclusions within the central nervous system [5,6]. In
recent decades, the dRIT has been applied to enhance rabies surveillance in Africa, Eurasia,
and the Americas [8–18].
Within the Americas, programs for the elimination of human rabies caused by dogs
have resulted in significant regional progress [19]. Today, human and domestic animal cases
in this region are caused primarily from RABV transmission via rabid wildlife, particularly
from bats [20,21]. In North America, where canine RABV perpetuation has been eliminated,
the majority of dRIT applications have been in support of enhanced rabies surveillance
(ERS) activities focused upon the oral vaccination of free-ranging mesocarnivores, such
as raccoons [22–24]. In contrast, most cases of bat rabies are detected by public health
laboratories, after human exposure. Within the context of ERS and non-human exposures,
the aim of this study was to evaluate the potential utility of the dRIT in the diagnosis of
RABV in naturally infected rabid bats from the USA. Given progress to date during ERS
for multiple species, we hypothesized that our findings would support the benefits of the
dRIT as a useful diagnostic test as applied to other suspect wildlife, to confirm the presence
of RABV in affected bat populations.
2. Materials and Methods
2.1. Samples
Brains originated from suspect bats that were collected as part of routine public health
laboratory testing or ERS in Texas and Arizona, respectively, as described for the USA [24].
Brains were kept frozen (−20 to −80 ◦ C) until analysis. The first preliminary evaluation
was a retrospective examination of coded bat brain samples obtained from Texas, which
had been evaluated via the DFAT by the Texas Department of Health during 2016. Findings
by the dRIT were obtained and recorded, before unblinding of prior testing results.
The sample set from Arizona consisted of brains collected from bats as part of ERS,
without a history of human or domestic animal exposure, during the period 2016–2020
and were tested prospectively by the dRIT. After evaluation, results were confirmed by the
DFAT at the Wadsworth Center Rabies Laboratory, New York State Department of Health.
2.2. Protocol
The dRIT protocol was performed using the Wistar Institute purified and biotinylated
anti-RABV ribonucleoprotein murine monoclonal antibodies (MAbs) 502 and 802, as described [25,26]. Briefly, touch impressions of bat brains were made on glass microscope
slides. The slides were air-dried, fixed in 10% buffered formalin for 10 min, dip-rinsed
in wash buffer of PBS with 1% Tween 80 (TPBS), immersed in 3% hydrogen peroxide for
10 min, and dip-rinsed in fresh TPBS. After dipping, excess buffer was shaken from the
slides and blotted from the edges (repeated after each rinse). Slides were incubated in a
humidity chamber (i.e., a plastic cover on a moistened paper towel) with the anti-RABV
MAbs for 10 min, dip-rinsed in TPBS, incubated with a streptavidin-peroxidase complex
for 10 min and dipped in TPBS. A 3-amino-9-ethylcarbazole (AEC) stock solution was
prepared by dissolving one 20 mg AEC tablet in 4 mL of N, N-dimethylformamide. A
working dilution was prepared by adding 1 mL of AEC stock solution to 14 mL of 0.1 mol/L
acetate buffer and 0.15 mL 3% hydrogen peroxide. Slides were incubated with the AEC
peroxidase substrate for 10 min, dip-rinsed in distilled water, and were counterstained
with Gill’s formulation #2 hematoxylin, diluted 1:2 with distilled water for 2 min and
dip-rinsed in distilled water. Slides were mounted with a water-soluble mounting medium
and examined by light microscopy (Leica Microsystems Inc., Buffalo Grove, IL, 60089, USA)
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at magnifications of 200× to 400× for detection of typical RABV antigens (i.e., appearing
as magenta-stained inclusions against a faint, bluish background, using the selected chromogen for this protocol), compared to positive and negative control brain samples. After
generation of the dRIT data, the results of the DFAT upon bat brains were chosen as being
informative as the gold standard, for definition of true positive, true negative, false positive,
and false negative values.
2.3. Analysis
Based upon the comparison of the dRIT results with the findings from the DFAT, the
diagnostic sensitivity (Se), specificity (Sp), positive predicted value (PPV), and negative
predicted value (NPV) were calculated [27].
3. Results
Fifty brains from 9 species were received from Texas, consisting of 20 rabid and 30 nonrabid bats (Table 1). After unblinding of the line list, compared to the DFAT, the dRIT
Se was 100% (0.832–1.0, 95% CI) and the Sp was 96.7% (0.828–0.992, 95% CI). A single
false-positive result was obtained from an evening bat, N. humeralis. Upon re-testing of
this sample, using a slightly thinner brain impression on the microscope slides, no RABV
antigens were detected using the dRIT.
Table 1. Comparison of Results Obtained upon Suspect Rabid Bat Brain Samples from Texas by the
Direct Fluorescent Antibody Test (DFAT) and the Direct Immunohistochemical Test (dRIT).
Bat

DFAT Positive

DFAT Negative

dRIT Positive

dRIT Negative

Mexican free-tailed bat, Tadarida brasiliensis

5

5

5

5

Evening bat, Nycticeius humeralis

5

5

6

4

Red bat, Lasiurus borealis

2

4

2

4

Northern yellow bat, Lasiurus intermedius

3

3

3

3

Tri-colored bat, Perimyotis subflavus

1

4

1

4

Hoary bat, Lasiurus cinereus

2

2

2

2

Cave bat, Myotis velifer

1

3

1

3

Seminole bat, Lasiurus seminolus

1

2

1

2

Southern yellow bat, Lasiurus ega

0

2

0

2

TOTALS

20

30

21

29

In Arizona, brains from 214 bats were tested by the dRIT, consisting of 15 species,
plus five samples unidentified to species (Table 2). One brain sample from a Mexican
free-tailed bat, T. brasilensis, was unsuitable for testing by both the dRIT and the DFAT, and
was not included in these totals. Compared to the DFAT of 97 positive and 117 negative
samples, the dRIT SE was 100% (0.963–1.0, 95% CI) and the Sp was 94% (0.881–0.976,
95% CI). There were 7 false-positive results: 2 Mexican free-tailed bats; 1 big brown bat;
1 canyon bat; 1 cave bat; and 1 lesser long-nosed bat (Figure 1). Negative, non-specific
staining appeared as infrequent dull, pinkish, or reddish background staining of brain
tissue, without distinctive magenta inclusions of various sizes and shapes, as detected in
rabid animals by the protocol employed in this dRIT application (i.e., in contrast to the
‘apple-green’ inclusions observed by fluorescent microscopy in the DFAT) [5,6]. Combining
the results of testing the 264 bat brain samples, representing 21 species from Arizona and
Texas, provided a Se of 100% (0.969–1.0, 95% CI) and a Sp of 94.6% (0.896–0.976, 95% CI),
with a PPV of 93.6% (0.878–0.972 95% CI) and a NPV of 100% (0.974–1.0, 95% CI).
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Table 2. Comparison of Results Obtained upon Suspect Rabid Bat Brain Samples from Arizona by
the Direct Fluorescent Antibody Test (DFAT) and the Direct Rapid Immunohistochemical Test (dRIT).
Bat

DFAT Positive

DFAT Negative

dRIT Positive

dRIT Negative

Mexican free-tailed bat, Tadarida brasiliensis

26

21

28

19

Big brown bat, Eptesicus fuscus

20

18

21

17

Canyon bat, Parastrellus hesperus

33

18

34

17

California myotis, Myotis californicus

2

3

2

3

Cave bat, Myotis velifer

4

20

5

19

Pallid bat, Antrozous pallidus

6

14

6

14

Lesser long-nosed bat, Leptonycteris yerbabuena

0

7

1

6

Western yellow bat, Lasiurus xanthinus

2

4

2

4

Yuma myotis, Myotis yumanensis

1

2

2

1

Hoary bat, Lasiurus cinereus

2

0

2

0

Western red bat, Lasiurus blossevillii

0

2

0

2

Arizona myotis, Myotis occultus

0

1

0

1

Western small-footed myotis, Myotis ciliolabrum

0

1

0

1

Big free-tailed bat, Nyctinomops macrotis

1

0

1

0

Townsend’s big-eared bat, Corynorhinus townsendii

0

1

0

1

Not identified

0

5

0

5

TOTAL

97

117

104

110

Zoonotic Dis. 2022, 2, FOR PEER REVIEW

(a)

5

(b)
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Discussion
the DFAT.

Prior research, focused primarily upon mesocarnivores, outlined the core benefits of
the dRIT during large-scale ERS in support of national programs for the oral vaccination
of wildlife [22,23]. The individual and combined Se/Sp of the dRIT in this study, obtained
upon a sample of naturally infected rabid bats, were comparable to prior findings and the
expectations obtained with the gold-standard comparator, the DFAT. For example, in a
recent summary of general DFAT findings, among 70 participants during routine laboratory proficiency testing, the Se was 97.9% (ranging from 66.7% to 100%), while the Sp was
96.1% (ranging from 33.3% to 100%) [28].
Regardless of the suggested additional supportive application for the critical utility
of the dRIT in ERS of affected wildlife, this preliminary study had several limitations.
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4. Discussion
Prior research, focused primarily upon mesocarnivores, outlined the core benefits of
the dRIT during large-scale ERS in support of national programs for the oral vaccination of
wildlife [22,23]. The individual and combined Se/Sp of the dRIT in this study, obtained
upon a sample of naturally infected rabid bats, were comparable to prior findings and the
expectations obtained with the gold-standard comparator, the DFAT. For example, in a
recent summary of general DFAT findings, among 70 participants during routine laboratory
proficiency testing, the Se was 97.9% (ranging from 66.7% to 100%), while the Sp was 96.1%
(ranging from 33.3% to 100%) [28].
Regardless of the suggested additional supportive application for the critical utility
of the dRIT in ERS of affected wildlife, this preliminary study had several limitations.
More than 40 different bat species occur throughout the USA, but our catchment area
only included two states in the southwestern portion of the country, restricted to a small
fraction of submitted samples, and reflective of less than 50% of the continental species
diversity. Considering state-wide totals, during 2019 alone, Arizona and Texas reported
138 and 565 rabid animals, including 55 and 289 rabid bats, respectively [24]. Moreover,
samples were not collected randomly. In Texas, specimens consisted of bats submitted to the
state health laboratory, primarily due to human or domestic animal exposures during 2016.
These included convenience samples of frozen brains that had been subject previously to the
DFAT, which were adequate in both relative quality and amount, for re-testing by the dRIT.
In Arizona, in contrast to retrospective testing of the Texas samples with a prior known
outcome in the DFAT, this activity involved prospective testing of bats without known
human or domestic animal exposure (e.g., animals found dead; bats provided after pest
control removal). In addition, most of the Arizona samples originated in the southeastern
portion of the state, primarily from a single county (i.e., Pima), and sample sizes were
constrained based upon dependence of those ERS specimens from a limited variety of
sources. Not unexpectedly, repercussions from the COVID-19 pandemic limited availability
of bat samples from cooperators during the period 2019–2020. Considering that each
year in the USA, tens of thousands of bats are submitted for laboratory testing, this study
contained only a very small cumulative fraction of this annual collection. Moreover, for both
state samples, in contrast to the multiple dRIT publications of alternative methodologies
used to date, a single harmonized protocol was performed in this investigation for RABV
detection and alternate outcomes might be expected, based upon the use of other MAb or
polyclonal conjugates, chromogens, equipment, technical expertise, species compositions,
and lyssavirus representations.
One other obvious drawback for general disease surveillance in bats is their relatively
small body size compared to mesocarnivores. Whereas recommendations for collection of
suspect mesocarnivores are explicit to avoid damaging the head, widespread guidelines for
humane killing of bats are often lacking, resulting in crushing and other severely traumatic
injuries, when submitted by the public. Consequently, tissue specimen quantity and quality
will vary greatly, due to predation, putrefaction, mummification, or other environmental
and ecological factors, such that identification of specific anatomical areas of the central
nervous system critical for definitive rabies diagnosis (i.e., the brainstem and cerebellum)
may be missing (Figure 2).
Despite these epidemiological biases, testing issues, and logistical concerns as encountered under many ERS conditions, technically the basic Se, Sp, PPV and NPV outcomes
obtained using the dRIT applied to this set of samples from bats were favorable. No false
negatives were recorded, and false positive results were limited to ~3% of total samples,
a finding which declined with the experience gained over time with routine dRIT use.
Negative, non-specific staining was uncommon, and may be related in part to tissue quality,
impression thickness, bacterial contamination, or other variables.
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Figure 2. Example of a submitted fringed myotis bat (Myotis thysanodes) sample, with no adequate brain tissue availability
Figure 2. Example of a submitted fringed myotis bat (Myotis thysanodes) sample, with no adequate
for testing by the dRIT.
brain tissue availability for testing by the dRIT.
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No false negatives were recorded, and false positive results were limited to ~3% of total
Just as the DFAT served as a confirmatory test to the dRIT during this study, the reverse
samples, a finding which declined with the experience gained over time with routine dRIT
could also be envisioned, whenever equivocal results are obtained in routine diagnostic
use. Negative, non-specific staining was uncommon, and may be related in part to tissue
testing for rabies. Additionally, the dRIT is economical to perform compared to the DFAT
quality, impression thickness, bacterial contamination, or other variables.
or molecular tests, which require more expensive equipment and maintenance [5,16,26].
Although molecular testing by real-time PCR and other modern methods is encourGiven the historical role of wildlife as lyssavirus reservoirs throughout Africa, Australia,
aged by central laboratories, the use of rapid RABV antigen detection assays by local
Eurasia and the Americas, incorporation of sensitive, specific, economical, practical, and depoint-of-care facilities is a key advantage of the dRIT, usually occurring in less than 1 h.
centralized diagnostic methods for rabies surveillance are needed for broader application
Just as the DFAT served as a confirmatory test to the dRIT during this study, the reverse
to a diverse array of mammalian species, especially under field conditions.

5. Conclusions
In addition to the use of the dRIT for ERS of rabies in mesocarnivore reservoirs, the test
is also suitable for RABV detection in bats. Inclusion of the dRIT for bats broadens pathogen
detection beyond traditional, centralized public health testing alone, improves the opportunity for identification of cross species transmission events and the emergence of novel RABV
variants, with consequent host shifts and potential long-term perpetuations [24,29,30]. To
this effect, continued application in areas such as Arizona is warranted, where realization
of the extension of bat RABV to meso-carnivores prompted timely management actions
towards active disease prevention and control, including the use of oral and parenteral
wildlife vaccination [29]. Considering its perpetuation among diverse wildlife such as bats,
rabies is not a candidate for eradication. However, routine extension of the dRIT and ERS
to other diverse geographic regions, mammalian species and lyssaviruses is encouraged,
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especially in tandem to the current focus upon the global elimination of human rabies
caused via dogs by 2030 [3,13–18].
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